SGLT2 Inhibitors Poised to Potentially Reshape Chronic Kidney Disease (CKD) and Diabetic Kidney Disease (DKD) Patient Care After AstraZeneca's Farxiga Approval
/PRNewswire/ -- Nephrologists have long considered chronic kidney disease (CKD) progression and diabetic kidney disease (DKD) as areas in dire need of new and...
Vifor Janssen Invokana Prnewswire Nephrologists Kristen Henn Ozempic Novo Nordisk Spherix Services Business Development
Source: prnewswire.com